Risk factors analysis of patients with non-small cell lung cancer complicated with chronic obstructive pulmonary disease after surgery

被引：0
|
作者：
Li, Haitian [1 ]
Lu, Xinwei [2 ]
Wang, Ping [3 ]
Wang, Ning [4 ]
Liu, Wenjing [4 ]
Song, Yamei [4 ]
Wang, Jing [4 ]
机构：
[1] Peoples Hosp Hengshui, Dept Infect Dis, Hengshui, Peoples R China
[2] Peoples Hosp Hengshui, Dept Nutr, Hengshui, Peoples R China
[3] Peoples Hosp Hengshui, Dept Geriatr, Hengshui, Peoples R China
[4] Peoples Hosp Hengshui, Dept Resp & Crit Care Med, 180 Middle Renmin Rd, Hengshui 053000, Hebei, Peoples R China
来源：
MINERVA SURGERY | 2025年
关键词：
D O I：
10.23736/S2724-5691.24.10673-9
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Mutational landscape of non-small cell lung cancer (NSCLC) associated with chronic obstructive pulmonary disease (COPD).
    Kawaguchi, Tomoya
    Koh, Yasuhiro
    Ando, Masahiko
    Isa, Shun-Ichi
    Tamiya, Akihiro
    Kubo, Akihito
    Yoshimoto, Naoki
    Kitagawa, Chiyoe
    Saka, Hideo
    Hirata, Kazuto
    Matsumura, Akihide
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [42] Impact of Chronic Obstructive Pulmonary Disease on the Mortality of Patients with Non-Small-Cell Lung Cancer
    Lee, Seung Jun
    Lee, Jinwoo
    Park, Young Sik
    Lee, Chang-Hoon
    Lee, Sang-Min
    Yim, Jae-Joon
    Yoo, Chul-Gyu
    Han, Sung Koo
    Kim, Young Whan
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (06) : 812 - 817
  • [43] Clinical characteristics and gene mutation profiles of chronic obstructive pulmonary disease in non-small cell lung cancer
    Yuan, Lin
    Guo, Ting
    Hu, Chengping
    Yang, Wei
    Tang, Xiaoli
    Cheng, Hao
    Xiang, Yang
    Qu, Xiangping
    Liu, Huijun
    Qin, Xiaoqun
    Qin, Ling
    Liu, Chi
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [44] Are patients with chronic obstructive pulmonary disease at a greater risk for the development of autoimmune thyroiditis as an adverse event of immunotherapy in non-small cell lung cancer treatment?
    Zecevic, Andrej
    Blanka-Protic, Ana
    Jandric, Aleksandar
    Adzic-Vukicevic, Tatjana
    PATHOLOGY & ONCOLOGY RESEARCH, 2025, 31
  • [45] Impact of anesthetic factors on prognosis of patients with non-small cell lung cancer after surgery
    Zhu, Wenzhi
    Li, Shuang
    Ji, Xinqiang
    Tan, Hongyu
    JOURNAL OF THORACIC DISEASE, 2023, 15 (09) : 4869 - 4884
  • [46] Outcomes of lobectomy on pulmonary function for early stage non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD)
    Wei, Sen
    Chen, Feng
    Liu, Renwang
    Fu, Dianxun
    Wang, Yanye
    Zhang, Bo
    Ren, Dian
    Ren, Fan
    Song, Zuoqing
    Chen, Jun
    Xu, Song
    THORACIC CANCER, 2020, 11 (07) : 1784 - 1789
  • [47] Influence of chronic obstructive pulmonary disease on postoperative lung function and complications in patients undergoing operations for primary non-small cell lung cancer
    Subotic, Dragan R.
    Mandaric, Dragan V.
    Eminovic, Tatjana M.
    Gajic, Milan M.
    Mujovic, Natasa M.
    Atanasijadis, Nikola D.
    Dzeletovic, Predrag P.
    Andric, Ljiljana D.
    Bulajic, Branka M.
    Dimitrijevic, Ivan D.
    Sobic, Dragana P.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2007, 134 (05): : 1292 - 1299
  • [48] Risk factors of cough in non-small cell lung cancer patients after video-assisted thoracoscopic surgery
    Lin, Rongjia
    Che, Guowei
    JOURNAL OF THORACIC DISEASE, 2018, 10 (09) : 5368 - 5375
  • [49] Effectiveness of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease after lobectomy due to non-small cell lung cancer - a single-center retrospective study
    Klimczak, Magdalena
    Piekielny, Damian
    Antczak, Adam
    Smigielski, Jacek
    Tworek, Damian
    ADVANCES IN RESPIRATORY MEDICINE, 2021, 89 (03) : 247 - 253
  • [50] Analysis of the risk factors for myelosuppression after concurrent chemoradiotherapy for patients with advanced non-small cell lung cancer
    Jiang, Nan
    Chen, Xiao-Cen
    Zhao, Yue
    SUPPORTIVE CARE IN CANCER, 2013, 21 (03) : 785 - 791
12345